Latest News & Features
Careers
Global law firm and Wall Street institution to join forces, forming one of the world’s five largest law firms by revenue and significantly expanding global and US market reach. 22 December 2025
%203.JPG/r%5Bwidth%5D=1280&r%5Bheight%5D=720/f40f8750-dee9-11f0-bcaa-670076bed379-Panel%201%20-%20Enabling%20Success%20(Greenberg%20Traurig%20Sponsored)%203.webp)
Americas
Speakers from Greenberg Traurig, Verdiva Bio, Halozyme, and Metsera discuss the implications of the USPTO’s 2024 §112 guidelines on life sciences patents. 22 December 2025
%202.JPG/r%5Bwidth%5D=1280&r%5Bheight%5D=720/fb086b50-dee7-11f0-bcaa-670076bed379-Keynote%205%20-%20Clinical%20Trials%20(J%20A%20Kemp%20Sponsored)%202.webp)
Europe
Amanda Simons, J A Kemp, explains how clinical research affects patentability in Europe and how clinical data can be used to strengthen protection. 22 December 2025
Biotechnology
Dirk Buehler, Maiwald, discusses how the “try and see” standard is applied before the EPO and its relevance in pharma and biotech cases. 22 December 2025
Europe
With its landmark ruling, the court has delivered guidance for patentees and litigants— including three takeaways for counsel and rights holders, explain Tobias Wuttke and Axel Berger of Bardehle Pagenberg. 19 December 2025
Europe
A UK appellate court has revived a key patent for the tech, finding flaws in the lower court’s handling of the case and obviousness analysis over prior art. 18 December 2025
Europe
The High Court’s ruling clarifies aspects of the SPC waiver but leaves unresolved questions relating to export-country rights and confidentiality, say Claire Phipps-Jones and Luke Norton of Bristows. 18 December 2025
Americas
The proponents of a petition denied by the Supreme Court said it addressed a conflict that was significant “not just for the pharmaceutical industry, but for all stakeholders in our patent system”. 17 December 2025
Careers
The firm’s new hire is known for advising Boston’s biotech, pharmaceutical and chemical companies on patent strategies and commercialising scientific inventions. 17 December 2025
Europe
High-value IP disputes are reshaping life sciences litigation, with perspectives from McDermott Will & Emery, Curevac, Regeneron, HGF, and the UPC. 17 December 2025